Skip to main navigation Skip to search Skip to main content

Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation

  • R. J. Shah
  • , J. M. Diamond
  • , E. Cantu
  • , J. Flesch
  • , J. C. Lee
  • , D. J. Lederer
  • , V. N. Lama
  • , J. Orens
  • , A. Weinacker
  • , D. S. Wilkes
  • , D. Roe
  • , S. Bhorade
  • , K. M. Wille
  • , L. B. Ware
  • , S. M. Palmer
  • , M. Crespo
  • , E. Demissie
  • , J. Sonnet
  • , A. Shah
  • , S. M. Kawut
  • S. L. Bellamy, A. R. Localio, J. D. Christie

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Abstract

Primary graft dysfunction (PGD) is a major cause of early mortality after lung transplant. We aimed to define objective estimates of PGD risk based on readily available clinical variables, using a prospective study of 11 centers in the Lung Transplant Outcomes Group (LTOG). Derivation included 1255 subjects from 2002 to 2010; with separate validation in 382 subjects accrued from 2011 to 2012. We used logistic regression to identify predictors of grade 3 PGD at 48/72 h, and decision curve methods to assess impact on clinical decisions. 211/1255 subjects in the derivation and 56/382 subjects in the validation developed PGD. We developed three prediction models, where low-risk recipients had a normal BMI (18.5-25 kg/m2), chronic obstructive pulmonary disease/cystic fibrosis, and absent or mild pulmonary hypertension (mPAP<40 mmHg). All others were considered higher-risk. Low-risk recipients had a predicted PGD risk of 4-7%, and high-risk a predicted PGD risk of 15-18%. Adding a donor-smoking lung to a higher-risk recipient significantly increased PGD risk, although risk did not change in low-risk recipients. Validation demonstrated that probability estimates were generally accurate and that models worked best at baseline PGD incidences between 5% and 25%. We conclude that valid estimates of PGD risk can be produced using readily available clinical variables.

Original languageEnglish
Pages (from-to)2188-2196
Number of pages9
JournalAmerican Journal of Transplantation
Volume15
Issue number8
DOIs
StatePublished - Aug 1 2015

Bibliographical note

Publisher Copyright:
© 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Funding

FundersFunder number
National Institutes of Health (NIH)HL096845, HL103836, HL088263, HL115354, HL081619, HL114626, HL087115
National Heart, Lung, and Blood Institute (NHLBI)R01HL096845

    Keywords

    • clinical research / practice
    • lung (allograft) function / dysfunction
    • lung failure / injury
    • lung transplantation / pulmonology

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Transplantation
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation'. Together they form a unique fingerprint.

    Cite this